Literature DB >> 20418283

Specific N-linked glycosylation sites modulate synthesis and secretion of von Willebrand factor.

Thomas A J McKinnon1, Elizabeth C Goode, Graeme M Birdsey, Agata A Nowak, Alain C K Chan, David A Lane, Michael A Laffan.   

Abstract

We examined the role that N-linked glycans play in the synthesis and expression of von Willebrand Factor (VWF). Blocking the addition of N-linked glycans (NLGs) or inhibiting initial glycan processing prevented secretion of VWF. To determine whether specific glycosylation sites were important, the 16 VWF N-linked glycosylation sites were mutated followed by expression in HEK293T cells. Four NLG mutants affected VWF expression: N99Q (D1 domain), N857Q (D' domain), N2400Q (B1 domain), and N2790Q (CK domain) either abolished or reduced secretion of VWF and this was confirmed by metabolic labeling. Multimer analysis of mutant N2790Q cell lysate revealed an increase in VWF monomers, which was also observed when the isolated CK domain was expressed with N2790 mutated. Immunofluorescence microscopy showed that mutants N99Q, N857Q, and N2790Q were primarily retained within the ER, producing only few pseudo Weibel-Palade bodies over longer time periods compared with wtVWF. All the variants also showed an increase in free thiol reactivity. This was greatest with N857Q and D4-C2 NLG mutants, which had approximately 6-fold and 3- to 4-fold more free thiol reactivity than wtVWF. These data provide further evidence of the critical role that individual N-linked glycans play in determining VWF synthesis and expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20418283     DOI: 10.1182/blood-2010-02-267450

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms.

Authors:  Ashley Cartwright; Simon J Webster; Annika de Jong; Richard J Dirven; Lisa D S Bloomer; Ahlam M Al-Buhairan; Ulrich Budde; Christer Halldén; David Habart; Jenny Goudemand; Ian R Peake; Jeroen C J Eikenboom; Anne C Goodeve; Daniel J Hampshire
Journal:  Blood Adv       Date:  2020-07-14

2.  N-glycosylation of ovomucin from hen egg white.

Authors:  Marina Offengenden; Messele A Fentabil; Jianping Wu
Journal:  Glycoconj J       Date:  2011-04-12       Impact factor: 2.916

3.  An Insight into Glyco-Microheterogeneity of Plasma von Willebrand Factor by Mass Spectrometry.

Authors:  Ebtesam A Gashash; Arya Aloor; Dong Li; He Zhu; Xiao-Qian Xu; Cong Xiao; Junping Zhang; Aishwarya Parameswaran; Jing Song; Cheng Ma; Weidong Xiao; Peng George Wang
Journal:  J Proteome Res       Date:  2017-07-27       Impact factor: 4.466

4.  Factor VIII and vWF deficiency in STT3A-CDG.

Authors:  Irene J Chang; Heather M Byers; Bobby G Ng; John Lawrence Merritt; Reid Gilmore; Shiteshu Shrimal; Wei Wei; Yuan Zhang; Amanda B Blair; Hudson H Freeze; Bin Zhang; Christina Lam
Journal:  J Inherit Metab Dis       Date:  2019-01-30       Impact factor: 4.982

5.  The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels.

Authors:  Natalia Rydz; Laura L Swystun; Colleen Notley; Andrew D Paterson; J Jacob Riches; Kate Sponagle; Boonchai Boonyawat; Robert R Montgomery; Paula D James; David Lillicrap
Journal:  Blood       Date:  2013-03-25       Impact factor: 22.113

Review 6.  Genetic regulation of plasma von Willebrand factor levels in health and disease.

Authors:  L L Swystun; D Lillicrap
Journal:  J Thromb Haemost       Date:  2018-10-30       Impact factor: 5.824

Review 7.  Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.

Authors:  James T B Crawley; Rens de Groot; Yaozu Xiang; Brenda M Luken; David A Lane
Journal:  Blood       Date:  2011-06-29       Impact factor: 22.113

8.  In vivo analysis of the role of O-glycosylations of von Willebrand factor.

Authors:  Idinath Badirou; Mohamad Kurdi; Paulette Legendre; Julie Rayes; Marijke Bryckaert; Caterina Casari; Peter J Lenting; Olivier D Christophe; Cecile V Denis
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

9.  Desialylation of O-glycans activates von Willebrand factor by destabilizing its autoinhibitory module.

Authors:  Kayleigh M Voos; Wenpeng Cao; Nicholas A Arce; Emily R Legan; Yingchun Wang; Asif Shajahan; Parastoo Azadi; Pete Lollar; Xiaohui Frank Zhang; Renhao Li
Journal:  J Thromb Haemost       Date:  2021-09-26       Impact factor: 16.036

10.  Extreme C-terminal sites are posttranslocationally glycosylated by the STT3B isoform of the OST.

Authors:  Shiteshu Shrimal; Steven F Trueman; Reid Gilmore
Journal:  J Cell Biol       Date:  2013-03-25       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.